Dyne Therapeutics
$18.73
26
+$0.54+2.97% Monday 20:00
Statistics
Day High
19.39
Day Low
18.19
52W High
25
52W Low
8.06
Volume
1,597,676
Avg. Volume
-
Mkt Cap
3.09B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30JulExpected
Expected EPS
-0.750031
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-892.43MNet Income
Analyst Ratings
34.67Average Price Target
The highest estimate is 50.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DYN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sarepta Therapeutics
SRPT
Mkt Cap1.62B
Ionis Pharmaceuticals
IONS
Mkt Cap12.11B
PTC Therapeutics
PTCT
Mkt Cap5.88B
Solid Biosciences
SLDB
Mkt Cap724.59M
Wave Life Sciences
WVE
Mkt Cap1.13B
Ultragenyx Pharmaceutical
RARE
Mkt Cap2.4B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.81B
Alnylam Pharmaceuticals
ALNY
Mkt Cap37.76B
Editas Medicine
EDIT
Mkt Cap383.65M
About
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Show more...
CEO
Mr. John G. Cox M.B.A.
Employees
192
Country
United States
ISIN
US26818M1080
Listings
0 Comments
Share your thoughts
FAQ
What is Dyne Therapeutics stock price today?▼
The current price of DYN is $18.73 USD — it has increased by +2.97% in the past 24 hours. Watch Dyne Therapeutics stock price performance more closely on the chart.
What is Dyne Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dyne Therapeutics stocks are traded under the ticker DYN.
Is Dyne Therapeutics stock price growing?▼
DYN stock has risen by +4.52% compared to the previous week, the month change is a +8.33% rise, over the last year Dyne Therapeutics has showed a +35.53% increase.
What is Dyne Therapeutics market cap?▼
Today Dyne Therapeutics has the market capitalization of 3.09B
When is the next Dyne Therapeutics earnings date?▼
Dyne Therapeutics is going to release the next earnings report on July 30, 2026.
What were Dyne Therapeutics earnings last quarter?▼
DYN earnings for the last quarter are -0.73 USD per share, whereas the estimation was -0.77 USD resulting in a +5.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dyne Therapeutics revenue for the last year?▼
Dyne Therapeutics revenue for the last year amounts to 0 USD.
What is Dyne Therapeutics net income for the last year?▼
DYN net income for the last year is -892.43M USD.
How many employees does Dyne Therapeutics have?▼
As of June 16, 2026, the company has 192 employees.
In which sector is Dyne Therapeutics located?▼
Dyne Therapeutics operates in the Health & Wellness sector.
When did Dyne Therapeutics complete a stock split?▼
The last stock split for Dyne Therapeutics was on August 22, 2000 with a ratio of 2:1.
Where is Dyne Therapeutics headquartered?▼
Dyne Therapeutics is headquartered in Waltham, United States.